Bezafibrate therapy reduces serum hepatitis C virus (HCV) RNA titre in patients with chronic HCV infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1469, 2005-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PF 03491390 [IDN-6556] appears to lower aminotransferase activity in patients with chronic hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The monoclonal antibody XTL 002 [HCV-AB68] has potential in the treatment of chronic hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Interferon plus lamivudine may be effective in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

For patients with hepatitis C virus (HCV) infection who respond rapidly to peginterferon-α-2a, 8 weeks of therapy is as effective as a 24 weeks

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Etanercept is effective and "may be used safely" in patients with psoriatic arthritis and concurrent hepatitis C virus (HCV) infection

Inpharma, Vol. 1, Iss. 1466, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite